Accomplia Remonabant is unique as it acts to stop both food and cigarette cravings. In trial studies, Acomplia was found to help people lose an average of twenty pounds and doubled people’s chances of quitting smoking.
Accomplia, manufactured by the French pharmaceutical company, Sanofi-Aventis, is now available in the UK and will soon be available in Denmark, Ireland, Germany, Finland and Germany. Once Acomplia is approved for sale in the United States, Sanofi plans to market the drug under the name Zimulti.
One of the hot new diet drug in the news is the French drug called "Accomplia Rimonabant." It was created to help people quit smoking and lose fat by blocking circuitry in the brain that gives the body cravings. The diet drug, rimonabant accomplia, which could be available in a year or two, is an appetite suppressant, but works by an entirely new approach by blocking the same primeval circuitry in the brain that gives pot-smokers the munchies. The French firm Sanofi-Synthelabo plans to seek U.S. approval to sell it under the brand "Accomplia" after more studies are finished next year. A study found that the drug helped people drop 20 pounds in a year, while the other concluded it increased smokers' success at quitting, at least in the short-term. The drug will be marketed both for dieting and smoking cessation.
Generic Acomplia Zimulti & Branded Acomplia Rimonabant Prices Comparison
| Acomplia Store |
Dosage |
Shipping |
Price |
Price / Pill |
Acomplia Prices |
 |
28 Pills 20mg |
Worldwide
Generic Acomplia |
$59.00 |
$2.1 |
|
 |
28 Pills 20mg |
Europe
Branded Acomplia |
£128.99 |
£4.6 |
|
 |
28 Pills 20mg |
Worldwide
Except Europe
Branded Acomplia |
$228.00 |
$8.14 |
|
Doctors say the drug is noteworthy because it takes a different approach to helping people overcome their cravings for food and tobacco. It is the first of a class of medicines that blocks the so-called endocannabinoid system in the central nervous system.
Marijuana makes people hungry by stimulating this circuitry. The same biology serves crucial everyday purposes by helping the brain regulate hunger, including alcohol craving. Overeating and smoking can overstimulate this system, which in turn causes people to eat and smoke more. By temporarily blocking the body's ability to receive these signals, experts believe they can return the system to normal.
In the larger of the two studies, Dr. Jean-Pierre Despres of Laval University in Quebec City used 1,036 volunteers, all with stomachs that put them at high risk for heart problems. They were urged to cut 600 calories/day and given either accomplia or placebos.
After a year, those who got the higher of two doses of accomplia had lost an average of 20 pounds and trimmed three inches from their waists. Nearly half of them took off 10 percent of their body weight. By comparison, those on placebos lost just five pounds. Those receiving accomplia improved in other ways, as well: their levels of good cholesterol rose 23 percent, while their triglycerides fell 15 percent. |
